Create account

Coverage dated September 23, 2026

STAT+: Drugmakers, biotech VCs show ‘reinvigorated’ interest in osteoporosis treatments

Headline from STAT

Medicines for osteoporosis are grabbing the attention of the pharma industry, which has been incentivized by a long-awaited regulatory change.

STAT's own description from its feed. We collect headlines and these descriptions, not full articles; read the original reporting below.

Read the reports

Reports & sources

2 articles, oldest first.

  1. STAT

    STAT+: Drugmakers, biotech VCs show ‘reinvigorated’ interest in osteoporosis treatments (opens STAT)

    Published

    STAT's feed description

    Medicines for osteoporosis are grabbing the attention of the pharma industry, which has been incentivized by a long-awaited regulatory change.

  2. The Boston Globe

    Drugmakers, biotech VCs show ‘reinvigorated’ interest in osteoporosis treatments (opens The Boston Globe)

    Published

    The Boston Globe's feed description

    A shift by the FDA and frustration with existing therapies have created new opportunities.

STAT+: Drugmakers, biotech VCs show ‘reinvigorated’ interest in osteoporosis treatments | Since Then